Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in Non-diabetic Chronic Kidney Disease
NCT07344922Phase 3Completed
- Sponsor
- Mansoura University
- Start
- Sep 2022
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dapagliflozin in chronic kidney disease (CKD), anemia, cardiovascular calcification, sponsored by Mansoura University. Started Sep 2022; status: completed.
02
Drugs
dapagliflozin
03
Conditions
chronic kidney disease (CKD)anemiacardiovascular calcification
Beyond the preview
Go deeper on NCT07344922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07344922.